No Cover Image

Journal article 152 views 19 downloads

The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials / Lawrence A. Leiter, Steve Bain, Deepak L. Bhatt, John B. Buse, C. David Mazer, Richard E. Pratley, Søren Rasmussen, Maria Sejersten Ripa, Hrvoje Vrazic, Subodh Verma

Diabetes, Obesity and Metabolism

Swansea University Author: Steve Bain

  • 54314VOR.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution‐NonCommercial License (CC-BY-NC).

    Download (728.43KB)

Check full text

DOI (Published version): 10.1111/dom.14079

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54314
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: blood pressure, cardiovascular, liraglutide, MACE, semaglutide